Increasing Community Pharmacy Involvement in the Prevention of Cardiovascular Disease Project
Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives
Monash
450 participants
Jun 17, 2009
Interventional
Conditions
Eligibility
Inclusion Criteria2
- Using or have used one or more antihypertensive medications (angiotensin converting enzyme inhibitors, angiotensin-II receptor antagonists, calcium channel blockers, beta blockers and thiazide diuretics) in the last 6 months, primary hypertension confirmed by the GP, and
- available for follow-up at 6 months.
Exclusion Criteria3
- Participation in other compliance promotion or medication profiling programs or receipt of a recent home medicines review, unavailable for follow-up, unable to
- communicate in English, and does not self-
- administer anti-hypertensive medicines.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A package of strategies (e.g. Home blood pressure monitoring, motivation interviewing, medication use review, home medicines review (where necessary), patient reminders (SMS, telephone, mail), and general practitioner referral (when needed). This intervention program is for 6 months and will be offered by the pharmacist at baseline, 3 months and 6 months. Each patient is provided with a blood pressure (BP) monitor and advised to carry out home montoring of their blood pressure every 2-3 days.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12609000705280